Login / Signup

Clinical prognostic risk analysis and progression factor exploration of primary breast lymphoma.

Jili DengLan MiXiaopei WangJun ZhuChen ZhangYuqin Song
Published in: Hematology (Amsterdam, Netherlands) (2022)
: This is the first study to explore the prognostic risk factors and relapse factorsof PB-DLBCL in a relatively large Chinese PBL cohort. Local breast and CNS recurrence after standard R-CHOP treatment were the main issues we are facing now.
Keyphrases
  • diffuse large b cell lymphoma
  • risk factors
  • heavy metals
  • blood brain barrier
  • free survival
  • replacement therapy
  • breast cancer risk